Semaglutide biosimilar(Shandong New Time Pharma)
司美格鲁肽生物类似药（山东新时代）
Report date: 2026/04/16 20:00:17
Base Information
Drug NameSemaglutide biosimilar(Shandong New Time Pharma)
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShandong New Time Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShandong New Time Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A